EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Serological and Immunological Markers in Dengue Fever: A Retrospective ELISA-Based Pilot Study from Trinidad and Tobago

Angel Justiz-Vaillant iD, Sachin Soodeen

Diagnostics · 01.08.2026 · 16 (15) · 2434

DOI: 10.3390/diagnostics16152434 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diagnostics, online erschienen am 01.08.2026. Verfasst von Angel Justiz-Vaillant und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology/Microbiology and Pharmacology, Faculty of Medical Sciences, University of the West Indies, St. Augustine 330912, Trinidad and…. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Dengue fever remains a major mosquito-borne viral disease in tropical and subtropical regions and continues to represent an important public health challenge in the Caribbean. Despite endemic transmission in Trinidad and Tobago, limited laboratory-based studies have evaluated serological markers associated with recent dengue infection.

Objective

To evaluate serological and immunological markers associated with recent dengue virus infection through the detection of anti-dengue virus immunoglobulin M (IgM) antibodies in serum samples obtained from Trinidad and Tobago using an enzyme-linked immunosorbent assay (ELISA).

Methods

Anti-dengue virus IgM antibodies were detected using a commercial enzyme-linked immunosorbent assay (ELISA). Results were classified as positive, borderline or negative according to manufacturer-recommended criteria. Descriptive statistical analysis was performed to determine seroprevalence in anonymized serum samples.

Results

A total of 161 serum samples were analyzed. Twenty samples (12.4%) demonstrated positive anti-dengue IgM reactivity, while 29 samples (18.0%) showed borderline reactivity and 112 samples (69.6%) were negative. Under the conservative analytical approach, the estimated dengue IgM seroprevalence was 12.4% (20/161; 95% CI: 7.7–18.6%).

Conclusions

The estimated seroprevalence of dengue IgM in this pilot study was highly dependent on the analytical treatment of borderline ELISA results. Conservative classification provided the most cautious and reproducible estimate of recent dengue infection, while liberal interpretation substantially increased the apparent disease burden. Early viral replication triggers inflammation that progresses to cytokine-driven vascular damage, while cross-reactive humoral responses and host factors ultimately shape dengue severity. Ultimately, understanding the drivers of IgM cross-reactivity is essential for accurate dengue surveillance, outbreak detection, and clinical decision-making.

Schlagwörter

Stichwörter der Autor:innen

ELISAIgMTrinidad and Tobagodengue feverflavivirusseroprevalence

Autor:innen und Institutionen

  • Department of Pathology/Microbiology and Pharmacology, Faculty of Medical Sciences, University of the West Indies, St. Augustine 330912, Trinidad and Tobago.

ORCID-Profile: Angel Justiz-Vaillant

Zitieren

APA

Justiz-Vaillant, A., & Soodeen, S. (2026). Serological and Immunological Markers in Dengue Fever: A Retrospective ELISA-Based Pilot Study from Trinidad and Tobago. Diagnostics, 16(15), 2434. https://doi.org/10.3390/diagnostics16152434

Vancouver

Justiz-Vaillant A, Soodeen S. Serological and Immunological Markers in Dengue Fever: A Retrospective ELISA-Based Pilot Study from Trinidad and Tobago. Diagnostics. 2026;16(15):2434. doi:10.3390/diagnostics16152434

BibTeX
@article{JustizVaillant2026,
  author = {Justiz-Vaillant, Angel and Soodeen, Sachin},
  title = {Serological and Immunological Markers in Dengue Fever: A Retrospective ELISA-Based Pilot Study from Trinidad and Tobago},
  journal = {Diagnostics},
  year = {2026},
  volume = {16},
  number = {15},
  pages = {2434},
  doi = {10.3390/diagnostics16152434}
}
Kostenlos starten →